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Abstract
We sequenced the E gene and adjacent prM/M and NS1 junctions (1940 bp) of 48 Dengue-4 (DEN-4) isolates collected between 1981
and 1999 from 8 Caribbean islands and from 7 South and Central American countries. Phylogenetic analysis confirms a single introduction
in the early 1980s and a high degree of gene flow resulting in a pattern of evolution defined more by time period than geographic origin,
especially within the Caribbean basin. A modern Caribbean clade consisting of four distinct lineages has arisen, comprised of isolates from
Caribbean islands and nearby regions of South America. This clade is defined by three amino acid substitutions in the E (aa 163 and 351)
and NS1 (aa 52) proteins. These findings highlight the importance of migration and gene flow in dengue viral change and suggest that efforts
to understand disease dynamics in the Caribbean basin need to focus at regional, rather than local scales.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Dengue virus is a single-stranded, positive-sense RNA
virus belonging to the genus Flavivirus, family Flaviviri-
dae. There are four antigenically distinct serotypes (DEN-
1–4), all of which can cause dengue fever (DF), a relatively
mild febrile illness, or the potentially fatal dengue hemor-
rhagic fever (DHF) and dengue shock syndrome (DSS). The
four serotypes are closely related, and evidence suggests
that they represent at least three independent introductions
from sylvatic primates into human populations, with the
most recent occurring within the last 100 years (Wang et al.,
2000). Considered among the most important re-emergent
infectious diseases, dengue virus annually infects more than
50 million people globally, leading to approximately 10,000
DHF/DSS-related infant deaths (WHO, 1996).
The emergence of epidemic dengue in the Americas, as
well as worldwide, has been characterized by a rise in
hyperendemicity (the co-occurrence of multiple dengue se-
rotypes in the same locality). Before the 1980s, regional
outbreaks of dengue in the Americas were caused by single
serotypes and were geographically restricted and largely
self-limiting (Gubler, 1998). However, the elimination of
mosquito control programs and increases in urbanization
and global travel have significantly changed the epidemio-
logic landscape of the disease (Gubler, 1997; Gubler, 1998).
Since the early 1980s, dengue virus epidemics in the region
have become steadily larger and more frequent with a con-
comitant rise in the numbers of DHF/DSS cases (WHO,
1996). All four serotypes have now been reported in the
Caribbean basin and most epidemics have consisted of a
mixture of DEN serotypes (Dietz et al., 1996). This mount-
ing hyperendemicity is believed to be one of the most
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significant factors contributing to increases in disease se-
verity and DHF/DSS (Gubler, 1997). There is strong cor-
relation between disease severity and secondary infection
with a heterologous serotype: individuals experiencing a
second infection are at least 15 times more likely to contract
DHF/DSS (Halstead, 1988; Kliks et al., 1989; Thein et al.,
1997). Viral factors such as strain virulence may also play
a role in determining disease severity and thus contribute to
the changing pattern of the disease (Kliks, 1990; Morens et
al., 1991; Rico-Hesse et al., 1997; Vaughn et al., 2000).
There is mounting evidence that genetic change can lead to
shifts in the epidemic potential or pathogenicity of dengue
virus serotypes and their relatives (Gubler et al., 1981;
Leitmeyer et al., 1999; Brault et al., 2002; Bennett et al.,
manuscript submitted).
Here we describe the evolution of DEN-4 across the
Caribbean and adjacent regions since its arrival and estab-
lishment in 1981. Despite the importance of viral population
dynamics in disease severity, few studies have attempted to
characterize movement or gene flow among established
viral populations. Dengue viral serotypes can clearly spread
rapidly and colonize new areas: DEN-4 was introduced into
the Americas in 1981 and within three years had spread to
most countries in the region (Gubler, 1998). Once a sero-
type has been established, however, the relative impact of
continued gene flow and/or local viral evolution on disease
dynamics is unknown. Within a geographic area marked by
frequent viral exchange, local evolution and subsequent
spread of new variants could prove the most serious threat
for severe epidemic disease transmission.
We used a phylogenetic approach to examine region-
wide patterns of viral change in DEN-4 over the period of
its establishment in the area. The region of the genome
chosen for analysis included the entire envelope (E) gene
and flanking regions. Because of its role in host cell binding,
entry, and elicitation of immune response (Roehrig et al.,
1998), the E gene is the one most commonly surveyed in
dengue molecular epidemiologic studies (Lanciotti et al.,
1997; Rico-Hesse et al., 1997; Leitmeyer et al., 1999; Wang
et al., 2000). We investigated whether this serotype’s evo-
lution has been a regional phenomenon, marked by frequent
genetic exchange among localities, or whether it is instead
best characterized as a collection of discrete, independently
evolving populations undergoing little genetic exchange.
This type of information will be critical for identifying
geographic areas of high viral genetic diversity and regional
patterns of gene flow. Ultimately, by understanding the
links between viral evolution, gene flow and selection, it
should be possible to identity those viral lineages that are
most likely to spread and seed new epidemic cycles.
Results
The 48 DEN-4 virus sequences analyzed represent fif-
teen countries from the Greater and Lesser Antilles and
from South and Central America (Fig. 1). Sequences were
more than 94% similar and fell within the viral lineage
designated as “genotype II” by Lanciotti et al. (1997; Fig.
2). A total of 349 substitutions have occurred in the enve-
lope gene (or 0.018 substitutions per site) since DEN-4’s
introduction into the Caribbean basin, most of which (80%)
are silent mutations. The maximum divergence within this
Caribbean subset is still relatively low compared to the
degree of divergence that separates the two DEN-4 subtypes
(0.018 vs 0.06 substitutions per site). Nonetheless, as few as
one or two point mutations can have profound epidemio-
logic effects (Brault et al., 2002; Leitmeyer et al., 1999).
The initial introduction of DEN-4 into the Caribbean,
represented by the 1981 isolate from Dominica, underwent
little divergence until 1985: numerous Caribbean isolates
from the early 1980s, up to 1984, along with 1982 isolates
from northern South America (Suriname) fall together with
the introduction isolate at the base of our phylogram (Fig. 2,
expanded tree). We designated this group the “1981 intro-
duction group” (delineated by green bar labeled “A” in Fig.
2, expanded phylogeny). From 1985 onward, this introduc-
tion group has evolved into a well-supported modern Ca-
ribbean basin lineage or clade (labeled “B” in Fig. 2), at the
base of which fall divergent lineages from greater South and
Central America, including isolates from Ecuador (1994),
Honduras (1991), El Salvador (1993) and Mexico (1991,
1995).
The modern Caribbean basin clade as well as three of the
Central American isolates (El Salvador [1993] and Mexico
[1991, 1995]) are distinct from the introduction group by a
single amino acid change from methionine to threonine in
the E gene (amino acid position 163), a highly non-conser-
vative substitution from a hydrophobic to a polar amino acid
(Fig. 2, indicated by red bar on internal branch). The mod-
ern Caribbean basin clade (“B”) itself includes only isolates
collected after 1984, from the Caribbean, and nearby coastal
South America (Venezuela, Suriname), with the exception
of a single Costa Rican isolate from 1996. This well-sup-
ported lineage is distinctive based on two conservative
amino acid substitutions (Fig. 2, black bars), from isoleu-
cine to valine (amino acid position 351, E gene) and from
lysine to arginine (amino acid position 52, NS1 gene), in
addition to four silent base substitutions (not shown on
figure). Within this Caribbean basin lineage, isolates are
grouped more by year of isolation than by geographic ori-
gin.
The modern Caribbean basin clade (“B”) includes four
major and distinct lineages, none of which are defined by
amino acid changes across the region examined. They are
instead defined by anywhere from two to six silent base
substitutions and are well supported by bootstrap analysis.
The first lineage is comprised of Puerto Rican isolates from
1985 to 1987 (solid yellow bar at the base of lineage “B,”
Fig. 2). No isolates from other geographic areas fell within
this group, but this observation may reflect the paucity of
samples from other regions in the mid to late 1980s. An-
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other lineage within the modern Caribbean basin clade is
comprised of Puerto Rican isolates from 1986 (upper yellow
bar within “B,” Fig. 2) and 1990 to 1994, as well as a 1993
Barbadian isolate and a Trinidad isolate from 1994 (Fig. 2,
solid light-blue bars and lower solid dark-blue bar within
“B”). The third and fourth lineages within the modern Ca-
ribbean basin clade are associated, forming a group of mid
to late 1990s Caribbean isolates. Within this group, the third
lineage is composed of isolates collected between 1993 and
1996 in the Lesser Antilles (Barbados and Martinique),
Suriname and Costa Rica (Fig. 2, cross-hatched bar within
“B” and solid dark-blue bar immediately below). Finally,
the fourth lineage, best described as a late 1990s Caribbean
basin group, is geographically diverse within the Caribbean
basin and is composed of late 1990s isolates from Puerto
Rico (1998), the Bahamas (1998), and the Lesser Antilles
(1999; Fig. 2, solid red bar), along with a few earlier
isolates, i.e., Montserrat isolates from 1994, and a Venezu-
elan isolate from 1995 (Fig. 2, solid dark-blue bar immedi-
ately below red area). This lineage is supported 98% of the
time according to bootstrap analysis (Fig. 2).
There are three instances where isolates from the same
time period at a given locality fall into different lineages. A
1986 isolate from Puerto Rico (PR 1986 115) falls in to the
outside of the 1985–87 Puerto Rican lineage. Another
Puerto Rican isolate, from 1985 (PR 1985 M33), lies en-
tirely outside of lineage “B.” There are also two 1993
isolates from Barbados that appear in different lineages: one
in the early 1990s lineage (BDS 1993B) and the other in the
mid-1990s lineage (BDS 1993A). There was no evidence
for past recombination events in our dataset, at least across
the gene region examined.
Discussion
This is the first large-scale regional analysis of the dy-
namics of DEN-4 populations. Our samples were drawn
from multiple locations over the period that marked the rise
of endemic DEN-4 in the Americas. Phylogenetic evidence
is consistent with a single introduction and rapid coloniza-
tion of the Americas by DEN-4 “genotype II” during the
Fig. 1. Map of the Americas showing countries represented in this study. Regions within the Americas, i.e., Central America, South America, the Greater
Antilles and the Lesser Antilles, are labeled 1–4 respectively. Countries represented in this study are indicated by shading: Costa Rica, El Salvador, Honduras
and Mexico (Region 1); Ecuador, Suriname and Venezuela (Region 2); The Bahamas, Jamaica and Puerto Rico (Region 3); Barbados, Dominica, Martinique,
Montserrat and Trinidad (Region 4).
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Fig. 2. Maximum likelihood tree of DEN-4 based on nucleotide sequences of E gene and adjacent regions of membrane and NS1 gene (1940 bp) of 48 isolates
from around the Caribbean, Central and South America (1981–1999). The tree shown is expanded from a neighbor-joining tree representing the clade’s
position relative to Asian isolates of both the “genotype I” and “genotype II” DEN-4 subtypes (PHL (Philippines) 1984, THD (Thailand) 1978 and THD 1984
represent “genotype I”; IND (Indonesia) 1977, THD 1994 and NCD (New Caledonia) 1981 represent “genotype II” sample sequences acquired from
GenBank). Beside nodes of interest in the expanded American tree, we provide bootstrap support values representing the percentage of times the given node
was obtained, out of 1000 replicate neighbour-joining trees reconstructed under the ML substitution model (Posada and Crandall, 1998). The names of isolates
refer to country of origin and year of isolation. In cases where there is more than one isolate from a given country and year, a unique isolate number (and/or
letter) is also indicated. Countries represented are Bahamas (BAH), Barbados (BDS), Costa Rica (CRA), Dominica (DOM), Ecuador (ECD), El Salvador
(ELS), Honduras (HON), Jamaica (JAM), Puerto Rico (PR), Montserrat (MON), Martinique (MAR), Mexico (MEX), Suriname (SUR), Trinidad and Tobago
(TRI), and Venezuela (VEN). Scale shown represents number of nucleotide substitutions. Red and black bars on internal branches indicate instances of
non-synonymous base changes. Letters “A” and “B” indicate the “1981 introduction group” and “modern Caribbean clade” respectively, delineated by
right-marginal black boxes. Isolates from different time periods are delineated by different colors: 1981 to 1984 (green bar); 1985–1987 (yellow bar);
1990-1992 (light-blue bar); 1993–1996 (dark-blue bar); 1998–1999 (red bar). Isolates from the Caribbean basin have a solidly colored bar, whereas those
from greater South and Central America have cross-hatched bars. Clades are separated by white spaces in the color bar.
early 1980s. Early 1980s samples collected in the Americas
were similar to isolates collected in South East Asia and the
Pacific during that same time period (Fig. 2, unexpanded
tree). Since its introduction, several lineages have emerged
independently from the base of the phylogenetic tree sug-
gesting some degree of independent divergence of DEN-4
viral populations across the Americas (Fig. 2). Nonetheless,
the most striking aspect of our phylogeny was the clear
coupling of different regional populations through time,
which suggests a high degree of continual gene flow be-
tween populations. This pattern was particularly true within
the Caribbean basin, the region on which we focused our
sampling efforts. Indeed, most isolates collected after 1987
within the Caribbean basin, including coastal South Amer-
ica, fell within a single clade defined by three amino-acid
substitutions.
This major clade, the modern Caribbean basin clade,
consisted of a number of distinct lineages that were gener-
ally widespread and often temporally clustered. For exam-
ple, Lesser Antillean isolates from the early 1990s (BDS
1993B and TRI 1994) are clustered together but nested
within a larger group of Greater Antillean (Puerto Rican)
isolates from the same time period (Fig. 2; lower dark-blue
bar). Isolates from the same areas, but in 1999, fell within
another highly distinctive clade that again was grouped with
Greater Antillean isolates from the same time period (Fig. 2;
red bar). In view of the absence of any major Caribbean
basin lineages defined solely on the basis of geographic
location, ongoing genetic exchange is both common and
important in DEN-4 evolution in the Caribbean. The simul-
taneous circulation of isolates from different lineages in the
same locality (as seen in Puerto Rico, mid-1980s, and Bar-
bados, 1993) is evidence that significant variation co-exists
within a population, regardless of whether it derives from
mutation or gene flow. That these lineages or variants have
different long-term fates suggests that certain variants are
more successful than others, some seeding later outbreaks
while others became extinct. Analysis of a larger number of
isolates would be necessary to confirm this.
The pattern of DEN-4 evolution in the Caribbean basin is
perhaps not surprising given the enormous amount of social
and commercial activity within this region. Both human and
mosquito hosts can be transported freely throughout the
region via ships and commercial airliners that move fre-
quently between islands. Indeed, DEN-4 spread throughout
the Americas within the two years following its initial
diagnosis in Dominica in 1981. Rapid initial spread of
DEN-4 reflects to some extent the absence of a previous
infection history in the region. Dengue is an acute viral
illness and exposure to a serotype appears to provide life-
long immunity to that serotype (Gubler, 1997). Prior to the
1980s, DEN-4 was absent from the region; all individuals
were thus susceptible to the disease and viral spread would
be unimpeded by host immunity. Subsequent to the initial
epidemic, local host immunity could have acted as a barrier
to continued regional gene flow. However, our data suggest
that regional gene flow remains an important source of
variation within populations of DEN-4 in the region, effec-
tively unifying most of the Caribbean basin into a single
evolutionary unit.
Although our sampling design does not allow us to
identify specific transmission routes within the region, the
Lesser Antilles island chain provides an obvious bridge
between mainland South America and the Greater Antilles
and Bahamas. Trinidad, the southernmost island in the
Lesser Antilles, is just 11 km off the coast of Venezuela and
there is frequent traffic between the two both by air and by
sea. The divergent evolution of isolates from Central Amer-
ica and Ecuador may reflect weaker geographic and eco-
nomic links. Analysis of DEN-4 isolates from different
sublocalities within these mainland countries may help to
determine whether the divergent evolution is correlated with
geographic or economic factors. Despite the observed di-
vergence, similar branch lengths for given years of collec-
tion indicate that evolution has been occurring at a relatively
equal rate throughout the Americas. The presence of a
single Central American isolate within the modern Carib-
bean basin clade may indicate an instance of genetic ex-
change between the Caribbean islands and the mainland,
possibly the result of vertebrate host movement in the past.
We have no recent collections to determine the result of that
introduction. Analysis of a larger number of Central Amer-
ican isolates would be required to assess the degree of gene
flow between these regions and its importance in dengue
evolution.
The history of local evolution coupled with contempo-
raneous gene flow that we observe among DEN-4 popula-
tions has important epidemiologic ramifications. First, these
data clearly suggest that eradication and control efforts
should focus on a regional rather than local scale. Tradi-
tional control methods (e.g., education and vector control)
applied at a single location are unlikely to succeed over the
long term simply because the probability of recolonization
is very high. Second, high levels of gene flow effectively
expand susceptible host population size. This will allow for
the maintenance of continuous DEN-4 transmission cycles
throughout the region despite local or seasonal extinctions
(Anderson and May, 1979). Third, and more insidiously,
regional population dynamics marked by local evolution
and gene flow would facilitate the spread of better-adapted
DEN-4 variants. For dengue, which cycles between humans
and mosquitoes, selection could act to increase viral repli-
cation rate and/or alter antigenic properties in either host.
Both modes will likely have strong impact on viral trans-
mission rates and/or disease severity.
Relative to other viruses DEN-4 has an intermediate rate
of evolution of 4.0  104 to 1.0  103 substitutions per
site per year (Bennett et al., manuscript submitted; Jenkins
et al., 2002). There is a growing body of evidence that
suggests that viral genotype is important to virulence and
viral transmission potential and that a small number of
amino acid changes can have profound epidemiologic sig-
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nificance (Gubler et al., 1981; Gubler, 1997). For example,
Leitmeyer et al., (1999) suggest that the presence of a single
amino acid substitution in the envelope glycoprotein, the
dominant virus antigen, responsible for virus attachment,
fusion, and assembly (Gubler et al., 1981; Gubler, 1997;
Chen et al., 1996; Roehrig et al., 1998), is one of the
primary determinants of DHF in patients infected with
DEN-2.
Despite a history marked by viral gene flow and lineage
spread, there is no direct evidence in these data that adaptive
evolution is promoting the success and spread of newly
evolved lineages in the Caribbean. Of the three amino acid
changes that defined the modern Caribbean basin lineage,
two are highly conservative, and the third, although result-
ing in a hydrophobic to polar amino acid shift, does not fall
into a known antigenic domain of the envelope glycopro-
tein. Furthermore, subsequent evolution within the region
has been dominated by silent nucleotide substitutions. None
of the major lineages within the basin was defined by amino
acid changes within envelope and adjacent gene regions.
Nonetheless, natural selection in other viral gene regions
(undetectable in the present analysis) may be driving the
pattern of evolutionary change that we observe. The most
recent DEN-4 epidemic in Puerto Rico (1998) was domi-
nated by viruses bearing mutations within a non-structural
gene region under natural selection (Bennett et al., manu-
script submitted). Isolates from this 1998 epidemic fall
within a lineage that was detected as early as 1994 and is
presently widespread in the Caribbean basin (Bahamas,
Barbados, Montserrat, Suriname, Trinidad, and Venezuela;
Fig. 2). The Bahamas also experienced a DEN-4 epidemic
in 1998 (CAREC, 1999a; CAREC 1999b).
In the absence of animal models and in vitro correlates of
the disease, detailed examination of the pattern of genetic
change provides a powerful strategy toward understanding the
relationship between dengue viral genotype and changing dis-
ease dynamics. The pattern of DEN-4 evolution in the Amer-
icas shows a complex history of rapid colonization, local evo-
lution, and contemporary gene flow. Although there is some
evidence for extended periods of independent evolution within
the Americas, since DEN-4’s arrival, newly evolved genotypes
have regularly spread throughout the region. The Caribbean
basin, in particular, is defined by a history of high gene flow
irrespective of geopolitical boundaries. These types of popu-
lation dynamics will have significant impacts on efforts to
control and monitor the disease. DEN-4 is not the only sero-
type to demonstrate the ability to span regional boundaries: the
relatively recent (1994) re-emergence of DEN-3 in the Amer-
icas provides further evidence of the ability of the dengue virus
to spread rapidly (CDC, 1995; CAREC, 1999c; CAREC,
2000). A similar history of local evolution and migration will
likely define the population history of other dengue virus se-
rotypes. These data argue that efforts to understand disease
dynamics need to focus not only on local scales, but also on the
regional context in which these local populations exist.
Materials and methods
Viral archive, RNA extraction and RT-PCR
Virus isolates were obtained from the collections of the
Caribbean Epidemiology Centre (CAREC), Trinidad, and
the Centers for Disease Control and Prevention (CDC),
Dengue Branch, San Juan, Puerto Rico. At both CAREC
and CDC, viruses were isolated by culturing in C6/36 mos-
quito cells. Sera are regularly submitted to both CAREC and
CDC for laboratory testing by medical institutions through-
out the Caribbean and South and Central America, and
hence usually represent symptomatic infections. Since these
two institutions represent principal sources of dengue iden-
tification and serotyping in the Caribbean basin, viruses
deposited there provide the best available representation of
the symptomatic host population. We selected viruses from
the collections to represent the multiple localities and years
in which DEN-4 has been recorded since its most recent
introduction to the Americas. Table 1 shows the year, coun-
try of origin, and number of isolates included in this study.
Our samples consisted of 48 American DEN-4 isolates
(34 from Caribbean islands, 9 from South America, and 5
from Central America) from outbreaks and epidemics oc-
curring between 1981 and 1999. We extracted RNA from
samples using QIAamp Viral RNA Mini kits (Qiagen
GmbH, Germany) according to the manufacturer’s instruc-
tions. For each isolate, we amplified a 1940 bp region of the
genome encoding the envelope (E) gene and adjacent 3
region of the membrane gene (225 bp) and 5 portion of the
NS1 gene (353 bases) as two overlapping fragments (917 bp
and 1054 bp) in separate single-tube reverse transcriptase–
polymerase chain reactions (RT-PCRs). RT-PCR amplifi-
cation primer sequences are provided in Table 2. Where
necessary, RT-PCR products were purified prior to sequenc-
ing using Qiagen PCR purification kits (Qiagen GmbH,
Germany), as outlined by the manufacturer.
RT-PCR fragment sequencing
Cycle sequencing reactions were performed using Taq
DyeDeoxy Terminator Cycle Sequencing Kits (Applied Bio-
systems, Foster City, CA), according to the manufacturer’s
instructions, with sequencing primers described in Table 2. We
cleaned products by standard precipitation before sequencing
on an ABI PRISM 377 automated DNA sequencer (Applied
Biosystems, Foster City, CA). We aligned sequences against a
DEN-4 reference sequence (Zhao et al., 1986; GenBank num-
ber M14931) and combined fragments for a given isolate using
Sequencher 3.1.1 software (Gene Codes, MI) to obtain a con-
tinuous nucleotide sequence for each sample. All sequences
used in this study can be accessed in GenBank (Accession
numbers, in order of appearance in Table 1: AY152364–66
(Bahamas); AY152368, AY152375–76 (Barbados);
AY152104 (Costa Rica); AY152360 (Dominica); AY152292
(Ecuador); AY152300 (El Salvador); AY152379 (Honduras);
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AY152384, AY152389 (Jamaica); AY152100 (Martinique);
AY152378, AY152304 (Mexico); AY152369–71 (Monser-
rat); AY152056, AY152068, AY152112, AY152144,
AY152148, AY152188, AY152208, AY152224, AY152236,
AY152268, AY152336, AY152344, AY152855-57 (Puerto
Rico); AY152372–74, AY152385– 88 (Suriname);
AY152367, AY152377, AY152380-83 (Trinidad); AY152092
(Venezuela)).
Phylogenetic analysis
Sequences were aligned together in MEGALIGN v 3.1.7
(Lasergene), using the Clustal algorithm (Higgins and
Sharp, 1988; Higgins et al., 1996). A phylogenetic tree
consisting of 56 isolates was generated using PAUP 4.0b8
(Swofford, 1998). We based tree calculations on models of
sequence evolution whose parameters were estimated by
maximum likelihood, using Modeltest 3.06 PPC (Posada
and Crandall, 1998). The resultant phylogenetic tree was
rooted with the 1981 isolate from Dominica, believed to
represent the first introduction of the serotype into the
Americas. We assessed the reliability of the tree topology
by bootstrapping the data set 1000 times to generate neigh-
bor-joining trees. Internal nodes of particular interest are
labeled with percent times obtained, if greater than 50
(Fig. 2).
Recombination between viruses, both within and be-
tween serotypes, has been demonstrated in dengue (Holmes
et al., 1999; Worobey et al., 1999) and can lead to erroneous
and conflicting phylogenetic relationships. We examined
our dataset for recombinants by comparing neighbor-joining
trees based on 500 continuous bases at a time for incongru-
ities. We then used LARD (Holmes et al., 1999), which
generates maximum likelihood scores for each set of isolate
Table 1
Location, year of isolation, and number of DEN-4 isolates included in this study
Country of
isolation
Date of isolation
1981 1982 1983 1984 1985 1986 1987 1990 1991 1992 1993 1994 1995 1996 1998 1999
Bahamas 3
Barbados 2 1
Costa Rica 1a
Dominica 1
Ecuador 1a
El Salvador 1a
Honduras 1
Jamaica 1 1
Martinique 1a
Mexico 1 1a
Monserrat 3
Puerto Rico 2a 2a 1a 2a 1a 3a 2a 2a
Suriname 4 3
Trinidad 2 2 1 1
Venezuela 1a
a Samples from Bennett et al., manuscript submitted.
Table 2
List of primers used to amplify and sequence envelope gene and adjacent regions of membrane and NSI genes of DEN-4
Primera Sequence Function Fragment Genome position
U486 5-CACGTATAAATGCCCCCTACTGGTC Amplification EnvA 486
L1786 5-GCTGTGTTTCTGCCATCTCTTTGTC Amplification EnvA 1786
U580 5-ACCCAGAGCGGAGAACGGAGACGAG Sequencing EnvA 580
L803 5-GGGGCGACCAGCATCATTAGGACAA Sequencing EnvA 803
U967 5-GAACTGACTAAGACAACAGCCAAGG Sequencing EnvA 967
L1136 5-AACAAGCCACAGCCATTGCCCCACC Sequencing EnvA 1136
U1363 5-CCGGACTATGGAGAACTAACACTCG Sequencing EnvA 1363
L1658 5-TGTCCTGCAAACATGTGATTTCCAT Sequencing EnvA 1658
U1568 5-GCAATGGTTTTTGAATCTGCCTCTT Amplification EnvB 1568
L2679 5-CCTTCACATCCCCAGCCACTACAGT Amplification EnvB 2679
U1602 5-GCAGGAGCAGACACATCAGAGGTTC Sequencing EnvB 1602
U2114 5-GAAAGGGAGTTCCATTGGCAAGATG Sequencing EnvB 2114
L1985 5-CAAAGGGGTGGATGAGATGATACGC Sequencing EnvB 1985
L2519 5-TCTCGCTGGGGACTCTGGTTGAAAT Sequencing EnvB 2519
a Designed by Bennett et al., manuscript submitted.
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triplet (potential recombinant and proposed parentals) rela-
tionships, with and without a supposed crossover event.
This identifies the most likely position for a potential break-
point. The significance of an improvement in likelihood
score by imposing a crossover event was assessed in two
ways: statistically, by likelihood ratio test against a chi-
square distribution for the appropriate degrees of freedom
(Holmes et al., 1999), and biologically, by examining the
overall phylogeny with and without a breakpoint inferred
for the given isolate. In this way we determined whether the
conflicting phylogenetic signal under suspicion was signif-
icant relative to the overall pattern of evolution, e.g.,
whether conflicting signals involved isolates from divergent
lineages and thus could impact the overall phylogeny, or
merely involved tip isolates within a given lineage.
In reporting our results we use several terms that appear
in both evolutionary biology and virology literature, but are
not always used in the same sense. For our purposes, we use
the term “genotype” in its traditional genetic sense, to refer
to the unique sequence of bases possessed by a single isolate
(we also may refer to such an individual as a “variant”).
Note that each isolate is actually a sample of multiple and
potentially variable virus particles within the host (Wang et
al., 2002) and presumably represents the most common
genotype present. Rare isolates with confirmed sequence
polymorphism(s), indicating the presence of multiple and
equally common genotypes/virions within a single sample,
were excluded from analyses. In contrast to our usage of the
term “genotype,” virologic nomenclature often uses the
term to refer to a class of similar (but not identical) isolates.
Instead, we use the terms “lineage” and “clade” to describe
groups of similar, and presumably related individuals that
share a common ancestor (monophyletic), when that rela-
tionship is supported at least 75% of the time by bootstrap
analysis. We refer to groups assigned this or a greater level
of support as “well-supported.”
Finally, in our phylogenetic analysis we consider genetic
changes at both the base pair and amino acid level, since the
former does not always result in the latter. Based on our
phylogenetic results, we discuss potential sources and pat-
terns of genetic variation, using the terms gene flow and
genetic exchange synonymously to refer to the movement of
viral genes and thus the movement of dengue viruses be-
tween populations (i.e., populations of viruses in their pop-
ulations of hosts). Because viruses are obligate parasites, the
movement of virus particles between populations is also
representative of the movement of hosts, either human host
or mosquito vector (unintentionally assisted by human
means).
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